July 31, 2023

Proceedings of the National Academy of Sciences publishes the discovery of two new subtypes of HPV-associated head and neck cancers

June 16, 2023

Media Advisory: Nature Medicine publishes key lessons from NCI-MATCH to guide future precision medicine trials

June 1, 2023

Press Release: ComboMATCH investigators are translating robust pre-clinical evidence for new anti-cancer drug combinations into a series of early-phase clinical trials

May 30, 2023

Group leaders talk with The Cancer Letter about the cisplatin chemotherapy shortage (login required)

April 21, 2023

Lancet Digital Health publishes the first validation of a CT-based deep learning tool for pre-treatment identification of head and neck cancer patients with high-risk, aggressive disease (in the context of the E3311 trial)

June 22, 2022

FDA approves dabrafenib plus trametinib for BRAF V600E-mutated tumors based on data from NCI-MATCH

June 1, 2022

Precision medicine clinical trials: A conversation between Peter O’Dwyer and Lale Kostakoglu

March 8, 2022

JAMA Oncology publishes TAILORx data showing racial and neighborhood disparities in breast cancer

March 1, 2022

FDA notes the NCI-MATCH trial in its release of new guidance on master protocols and expansion cohorts

ECOG-ACRIN Cancer Research Group